Patents Assigned to Immune System Therapeutics Ltd
  • METHOD FOR TREATING IMMUNE DISORDERS
    Publication number: 20120114555
    Abstract: The present invention relates to the treatment of B-cell mediated immune disorders such as rheumatoid arthritis, systemic lupus erythromatomus, diabetes mellitus, and multiple sclerosis. In particular, the present invention relates to the treatment of B-cell mediated immune disorders using antibodies which bind to membrane-bound free light chain expressed on the surface of plasma cell precursors.
    Type: Application
    Filed: April 7, 2010
    Publication date: May 10, 2012
    Applicant: IMMUNE SYSTEM THERAPEUTICS LTD
    Inventors: Andrew T. Hutchinson, Darren R. Jones, Robert L. Raison, Parisa Asvadi, Rosanne D. Dunn
  • Method for treating multiple myeloma
    Patent number: 7838041
    Abstract: The present invention relates to methods for the treatment of multiple myeloma. More particularly, the present invention relates to a method for inducing apoptosis in myeloma cells by administration of a K121-like antibody.
    Type: Grant
    Filed: January 18, 2008
    Date of Patent: November 23, 2010
    Assignee: Immune System Therapeutics Ltd
    Inventors: Robert Lindsay Raison, Rosanne Dorothy Dunn, Boon Hwa Andre Choo
  • Method for treating multiple myeloma
    Patent number: 7556803
    Abstract: The present invention relates to methods for the treatment of multiple myeloma. More particularly, the present invention relates to a method for inducing apoptosis in myeloma cells by administration of a K121-like antibody.
    Type: Grant
    Filed: January 18, 2008
    Date of Patent: July 7, 2009
    Assignee: Immune System Therapeutics Ltd
    Inventors: Robert Lindsay Raison, Rosanne Dorothy Dunn, Boon Hwa Andre Choo
  • Method for treating multiple myeloma
    Patent number: 7344715
    Abstract: The present invention relates to methods for the treatment of multiple myeloma. More particularly, the present invention relates to a method for inducing apoptosis in myeloma cells by administration of a K121-like antibody.
    Type: Grant
    Filed: July 5, 2002
    Date of Patent: March 18, 2008
    Assignee: Immune System Therapeutics Ltd
    Inventors: Robert Lindsay Raison, Rosanne Dorothy Dunn, Boon Hwa Andre Choo